Bartonella bacilliformis is the etiologic agent of bartonellosis (Carrion's disease), a biphasic disease that is endemic among inhabitants of the western slopes of the Andes in Columbia, Ecuador, and Peru (11,14). The disease consists of a primary, acute, hematic phase characterized by fever, hemolytic anemia, and bacteremia, referred to as Oroya fever. This is followed by a secondary, chronic phase characterized by skin eruptions, referred to as verruga peruana. During the hematic phase, B. bacilliformis parasitizes almost 100% of the erythrocytes, resulting in their premature destruction, and leading to a very severe form of hemolytic anemia. In the secondary phase, B. bacilliformis invades endothelial cells, causing hemangiomas, possibly as a result of hyperproliferation of the terminal vasculature of the dermis and subcutaneous tissue (10). These hemangiomas bear a distinct clinical and histologic similarity to the hemangioma-like lesions of bacillary (epitheliod) angiomatosis (BA), which has now been associated with the newly described bacterium Bartonella henselae (previously, Rochalimaea henselae) (4,26,27). Interestingly, B. bacilliformis and B. henselae are also closely related phylogenetically, and it was suggested that these bacteria may have a common mechanism of pathogenesis (1).We were interested in isolating and characterizing immunodominant B. bacilliformis antigens because of their potential usefulness in diagnosis and in elucidating the pathogenesis of bartonellosis. Additionally, the presence of homologs of these antigens in B. henselae might be interesting from the standpoint of the pathological similarities between the lesions of verruga peruana and BA. To isolate immunodominant antigens of B. bacilliformis, we constructed a B. bacilliformis genomic DNA library and screened it with serum from a patient with the chronic verruga phase of bartonellosis. In this report, we describe the isolation and initial characterization of one of the clones expressing a 75-kDa antigen of B. bacilliformis. Based on the strong amino acid sequence homology with the cell division protein FtsZ, we suggest that the 75-kDa antigen is the B. bacilliformis homolog of FtsZ (FtsZ Bb ). This is the first study that shows that FtsZ proteins are immunogenic in humans.
MATERIALS AND METHODSBacterial strains, plasmids, media, and serum. B. bacilliformis KC584 (ATCC 35686) and KC583 (ATCC 35685) were grown on heart infusion agar plates supplemented with 5% defibrinated rabbit blood (BBL) at 28°C for 6 to 8 days. Bacteria were harvested and resuspended in phosphate-buffered saline. The cells were then collected by centrifugation at 8,000 ϫ g, and the supernatant was discarded. The pellets were then resuspended in TE (10 mM Tris [pH 8.0], 1 mM EDTA) for DNA extraction.The XL-1Blue strain of Escherichia coli (Stratagene, Torrey Pines, La Jolla, Calif.) was grown on Luria broth (LB) with tetracycline (12.5 g/ml) or LB with ampicillin (50 g/ml) when transformed with pBluescript (Stratagene). E. coli SOLR cells were grown on LB wi...